Completed
Safety and Immunogenicity of a Trivalent Group B Streptococcus Vaccine in Healthy Pregnant Women
NCT02046148
- Conditions
- GBS Disease, Streptococcus Agalactiae
- Locations
-
- GSK Investigational Site Aurora, Colorado, United States
- GSK Investigational Site Baltimore, Maryland, United States
- GSK Investigational Site Durham, North Carolina, United States
- GSK Investigational Site Pittsburgh, Pennsylvania, United States